Table of Content

1 Report Overview
1.1 Childhood Vaccines Definition
1.2 Market by Type
1.2.1 Global Childhood Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Recombinant Vaccines
1.2.3 Viral Vaccines
1.2.4 Polysaccharide Vaccines
1.2.5 Others
1.3 Market Segment by Application
1.3.1 Global Childhood Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Childhood Vaccines Sales
2.1 Global Childhood Vaccines Revenue Estimates and Forecasts 2018-2034
2.2 Global Childhood Vaccines Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Childhood Vaccines Revenue by Region
2.3.1 Global Childhood Vaccines Revenue by Region (2018-2024)
2.3.2 Global Childhood Vaccines Revenue by Region (2024-2034)
2.4 Global Childhood Vaccines Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Childhood Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Childhood Vaccines Sales Quantity by Region
2.6.1 Global Childhood Vaccines Sales Quantity by Region (2018-2024)
2.6.2 Global Childhood Vaccines Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Childhood Vaccines Sales Quantity by Manufacturers
3.1.1 Global Childhood Vaccines Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Childhood Vaccines Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Childhood Vaccines Sales in 2022
3.2 Global Childhood Vaccines Revenue by Manufacturers
3.2.1 Global Childhood Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global Childhood Vaccines Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Childhood Vaccines Revenue in 2022
3.3 Global Childhood Vaccines Sales Price by Manufacturers
3.4 Global Key Players of Childhood Vaccines, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Childhood Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Childhood Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Childhood Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Childhood Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Childhood Vaccines Sales Quantity by Type
4.1.1 Global Childhood Vaccines Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Childhood Vaccines Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Childhood Vaccines Sales Quantity Market Share by Type (2018-2034)
4.2 Global Childhood Vaccines Revenue by Type
4.2.1 Global Childhood Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global Childhood Vaccines Forecasted Revenue by Type (2024-2034)
4.2.3 Global Childhood Vaccines Revenue Market Share by Type (2018-2034)
4.3 Global Childhood Vaccines Price by Type
4.3.1 Global Childhood Vaccines Price by Type (2018-2024)
4.3.2 Global Childhood Vaccines Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Childhood Vaccines Sales Quantity by Application
5.1.1 Global Childhood Vaccines Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Childhood Vaccines Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Childhood Vaccines Sales Quantity Market Share by Application (2018-2034)
5.2 Global Childhood Vaccines Revenue by Application
5.2.1 Global Childhood Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global Childhood Vaccines Forecasted Revenue by Application (2024-2034)
5.2.3 Global Childhood Vaccines Revenue Market Share by Application (2018-2034)
5.3 Global Childhood Vaccines Price by Application
5.3.1 Global Childhood Vaccines Price by Application (2018-2024)
5.3.2 Global Childhood Vaccines Price Forecast by Application (2024-2034)
6 North America
6.1 North America Childhood Vaccines Sales by Company
6.1.1 North America Childhood Vaccines Revenue by Company (2018-2024)
6.1.2 North America Childhood Vaccines Sales Quantity by Company (2018-2024)
6.2 North America Childhood Vaccines Market Size by Type
6.2.1 North America Childhood Vaccines Sales Quantity by Type (2018-2034)
6.2.2 North America Childhood Vaccines Revenue by Type (2018-2034)
6.3 North America Childhood Vaccines Market Size by Application
6.3.1 North America Childhood Vaccines Sales Quantity by Application (2018-2034)
6.3.2 North America Childhood Vaccines Revenue by Application (2018-2034)
6.4 North America Childhood Vaccines Market Size by Country
6.4.1 North America Childhood Vaccines Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Childhood Vaccines Revenue by Country (2018-2034)
6.4.3 North America Childhood Vaccines Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Childhood Vaccines Sales by Company
7.1.1 Europe Childhood Vaccines Sales Quantity by Company (2018-2024)
7.1.2 Europe Childhood Vaccines Revenue by Company (2018-2024)
7.2 Europe Childhood Vaccines Market Size by Type
7.2.1 Europe Childhood Vaccines Sales Quantity by Type (2018-2034)
7.2.2 Europe Childhood Vaccines Revenue by Type (2018-2034)
7.3 Europe Childhood Vaccines Market Size by Application
7.3.1 Europe Childhood Vaccines Sales Quantity by Application (2018-2034)
7.3.2 Europe Childhood Vaccines Revenue by Application (2018-2034)
7.4 Europe Childhood Vaccines Market Size by Country
7.4.1 Europe Childhood Vaccines Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Childhood Vaccines Revenue by Country (2018-2034)
7.4.3 Europe Childhood Vaccines Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Childhood Vaccines Sales by Company
8.1.1 China Childhood Vaccines Sales Quantity by Company (2018-2024)
8.1.2 China Childhood Vaccines Revenue by Company (2018-2024)
8.2 China Childhood Vaccines Market Size by Type
8.2.1 China Childhood Vaccines Sales Quantity by Type (2018-2034)
8.2.2 China Childhood Vaccines Revenue by Type (2018-2034)
8.3 China Childhood Vaccines Market Size by Application
8.3.1 China Childhood Vaccines Sales Quantity by Application (2018-2034)
8.3.2 China Childhood Vaccines Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Childhood Vaccines Sales by Company
9.1.1 APAC Childhood Vaccines Sales Quantity by Company (2018-2024)
9.1.2 APAC Childhood Vaccines Revenue by Company (2018-2024)
9.2 APAC Childhood Vaccines Market Size by Type
9.2.1 APAC Childhood Vaccines Sales Quantity by Type (2018-2034)
9.2.2 APAC Childhood Vaccines Revenue by Type (2018-2034)
9.3 APAC Childhood Vaccines Market Size by Application
9.3.1 APAC Childhood Vaccines Sales Quantity by Application (2018-2034)
9.3.2 APAC Childhood Vaccines Revenue by Application (2018-2034)
9.4 APAC Childhood Vaccines Market Size by Region
9.4.1 APAC Childhood Vaccines Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Childhood Vaccines Revenue by Region (2018-2034)
9.4.3 APAC Childhood Vaccines Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Childhood Vaccines Sales by Company
10.1.1 Middle East, Africa and Latin America Childhood Vaccines Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Childhood Vaccines Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Childhood Vaccines Market Size by Type
10.2.1 Middle East, Africa and Latin America Childhood Vaccines Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Childhood Vaccines Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Childhood Vaccines Market Size by Application
10.3.1 Middle East, Africa and Latin America Childhood Vaccines Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Childhood Vaccines Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Childhood Vaccines Market Size by Country
10.4.1 Middle East, Africa and Latin America Childhood Vaccines Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Childhood Vaccines Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Childhood Vaccines Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Overview
11.1.3 GSK Childhood Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 GSK Childhood Vaccines Products and Services
11.1.5 GSK Childhood Vaccines SWOT Analysis
11.1.6 GSK Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Childhood Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Sanofi Childhood Vaccines Products and Services
11.2.5 Sanofi Childhood Vaccines SWOT Analysis
11.2.6 Sanofi Recent Developments
11.3 Merck
11.3.1 Merck Company Information
11.3.2 Merck Overview
11.3.3 Merck Childhood Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Merck Childhood Vaccines Products and Services
11.3.5 Merck Childhood Vaccines SWOT Analysis
11.3.6 Merck Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Childhood Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Pfizer Childhood Vaccines Products and Services
11.4.5 Pfizer Childhood Vaccines SWOT Analysis
11.4.6 Pfizer Recent Developments
11.5 Jintan
11.5.1 Jintan Company Information
11.5.2 Jintan Overview
11.5.3 Jintan Childhood Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Jintan Childhood Vaccines Products and Services
11.5.5 Jintan Childhood Vaccines SWOT Analysis
11.5.6 Jintan Recent Developments
11.6 CSL
11.6.1 CSL Company Information
11.6.2 CSL Overview
11.6.3 CSL Childhood Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 CSL Childhood Vaccines Products and Services
11.6.5 CSL Childhood Vaccines SWOT Analysis
11.6.6 CSL Recent Developments
11.7 MedImmune LLC
11.7.1 MedImmune LLC Company Information
11.7.2 MedImmune LLC Overview
11.7.3 MedImmune LLC Childhood Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 MedImmune LLC Childhood Vaccines Products and Services
11.7.5 MedImmune LLC Childhood Vaccines SWOT Analysis
11.7.6 MedImmune LLC Recent Developments
11.8 J&J(Crucell)
11.8.1 J&J(Crucell) Company Information
11.8.2 J&J(Crucell) Overview
11.8.3 J&J(Crucell) Childhood Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 J&J(Crucell) Childhood Vaccines Products and Services
11.8.5 J&J(Crucell) Childhood Vaccines SWOT Analysis
11.8.6 J&J(Crucell) Recent Developments
11.9 China National Biotec
11.9.1 China National Biotec Company Information
11.9.2 China National Biotec Overview
11.9.3 China National Biotec Childhood Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 China National Biotec Childhood Vaccines Products and Services
11.9.5 China National Biotec Childhood Vaccines SWOT Analysis
11.9.6 China National Biotec Recent Developments
11.10 Tiantan
11.10.1 Tiantan Company Information
11.10.2 Tiantan Overview
11.10.3 Tiantan Childhood Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Tiantan Childhood Vaccines Products and Services
11.10.5 Tiantan Childhood Vaccines SWOT Analysis
11.10.6 Tiantan Recent Developments
11.11 Hualan
11.11.1 Hualan Company Information
11.11.2 Hualan Overview
11.11.3 Hualan Childhood Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 Hualan Childhood Vaccines Products and Services
11.11.5 Hualan Recent Developments
11.12 Kangtai
11.12.1 Kangtai Company Information
11.12.2 Kangtai Overview
11.12.3 Kangtai Childhood Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 Kangtai Childhood Vaccines Products and Services
11.12.5 Kangtai Recent Developments
11.13 Hissen
11.13.1 Hissen Company Information
11.13.2 Hissen Overview
11.13.3 Hissen Childhood Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.13.4 Hissen Childhood Vaccines Products and Services
11.13.5 Hissen Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Childhood Vaccines Value Chain Analysis
12.2 Childhood Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Childhood Vaccines Production Mode & Process
12.4 Childhood Vaccines Sales and Marketing
12.4.1 Childhood Vaccines Sales Channels
12.4.2 Childhood Vaccines Distributors
12.5 Childhood Vaccines Customers
13 Market Dynamics
13.1 Childhood Vaccines Industry Trends
13.2 Childhood Vaccines Market Drivers
13.3 Childhood Vaccines Market Challenges
13.4 Childhood Vaccines Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Childhood Vaccines Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Recombinant Vaccines
Table 3. Major Manufacturers of Viral Vaccines
Table 4. Major Manufacturers of Polysaccharide Vaccines
Table 5. Major Manufacturers of Others
Table 6. Global Childhood Vaccines Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Childhood Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Childhood Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Childhood Vaccines Revenue Market Share by Region (2018-2024)
Table 10. Global Childhood Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Childhood Vaccines Revenue Market Share by Region (2024-2034)
Table 12. Global Childhood Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Doses)
Table 13. Global Childhood Vaccines Sales by Region (2018-2024) & (K Doses)
Table 14. Global Childhood Vaccines Sales Market Share by Region (2018-2024)
Table 15. Global Childhood Vaccines Sales by Region (2024-2034) & (K Doses)
Table 16. Global Childhood Vaccines Sales Market Share by Region (2024-2034)
Table 17. Global Childhood Vaccines Sales Quantity by Manufacturers (2018-2024) & (K Doses)
Table 18. Global Childhood Vaccines Sales Quantity Share by Manufacturers (2018-2024)
Table 19. Global Childhood Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Childhood Vaccines Revenue Share by Manufacturers (2018-2024)
Table 21. Global Childhood Vaccines Price by Manufacturers 2018-2024 (USD/Dose)
Table 22. Global Key Players of Childhood Vaccines, Industry Ranking, 2021 VS 2022
Table 23. Global Childhood Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Childhood Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Childhood Vaccines as of 2022)
Table 25. Global Key Manufacturers of Childhood Vaccines, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Childhood Vaccines, Product Offered and Application
Table 27. Global Key Manufacturers of Childhood Vaccines, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Childhood Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 30. Global Childhood Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 31. Global Childhood Vaccines Sales Quantity Share by Type (2018-2024)
Table 32. Global Childhood Vaccines Sales Quantity Share by Type (2024-2034)
Table 33. Global Childhood Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Childhood Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Childhood Vaccines Revenue Share by Type (2018-2024)
Table 36. Global Childhood Vaccines Revenue Share by Type (2024-2034)
Table 37. Childhood Vaccines Price by Type (2018-2024) & (USD/Dose)
Table 38. Global Childhood Vaccines Price Forecast by Type (2024-2034) & (USD/Dose)
Table 39. Global Childhood Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 40. Global Childhood Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 41. Global Childhood Vaccines Sales Quantity Share by Application (2018-2024)
Table 42. Global Childhood Vaccines Sales Quantity Share by Application (2024-2034)
Table 43. Global Childhood Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Childhood Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Childhood Vaccines Revenue Share by Application (2018-2024)
Table 46. Global Childhood Vaccines Revenue Share by Application (2024-2034)
Table 47. Childhood Vaccines Price by Application (2018-2024) & (USD/Dose)
Table 48. Global Childhood Vaccines Price Forecast by Application (2024-2034) & (USD/Dose)
Table 49. North America Childhood Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 50. North America Childhood Vaccines Sales Quantity by Company (2018-2024) & (K Doses)
Table 51. North America Childhood Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 52. North America Childhood Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 53. North America Childhood Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 54. North America Childhood Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Childhood Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 56. North America Childhood Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 57. North America Childhood Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 58. North America Childhood Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Childhood Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 60. North America Childhood Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 61. North America Childhood Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Childhood Vaccines Sales Quantity by Country (2018-2024) & (K Doses)
Table 63. North America Childhood Vaccines Sales Quantity by Country (2024-2034) & (K Doses)
Table 64. Europe Childhood Vaccines Sales Quantity by Company (2018-2024) & (K Doses)
Table 65. Europe Childhood Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 66. Europe Childhood Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 67. Europe Childhood Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 68. Europe Childhood Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 69. Europe Childhood Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Childhood Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 71. Europe Childhood Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 72. Europe Childhood Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 73. Europe Childhood Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Childhood Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 75. Europe Childhood Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 76. Europe Childhood Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Childhood Vaccines Sales Quantity by Country (2018-2024) & (K Doses)
Table 78. Europe Childhood Vaccines Sales Quantity by Country (2024-2034) & (K Doses)
Table 79. China Childhood Vaccines Sales Quantity by Company (2018-2024) & (K Doses)
Table 80. China Childhood Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 81. China Childhood Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 82. China Childhood Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 83. China Childhood Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 84. China Childhood Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Childhood Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 86. China Childhood Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 87. China Childhood Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 88. China Childhood Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Childhood Vaccines Sales Quantity by Company (2018-2024) & (K Doses)
Table 90. APAC Childhood Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 91. APAC Childhood Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 92. APAC Childhood Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 93. APAC Childhood Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 94. APAC Childhood Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Childhood Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 96. APAC Childhood Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 97. APAC Childhood Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 98. APAC Childhood Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Childhood Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 100. APAC Childhood Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 101. APAC Childhood Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Childhood Vaccines Sales Quantity by Region (2018-2024) & (K Doses)
Table 103. APAC Childhood Vaccines Sales Quantity by Region (2024-2034) & (K Doses)
Table 104. Middle East, Africa and Latin America Childhood Vaccines Sales Quantity by Company (2018-2024) & (K Doses)
Table 105. Middle East, Africa and Latin America Childhood Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Childhood Vaccines Sales Quantity by Type (2018-2024) & (K Doses)
Table 107. Middle East, Africa and Latin America Childhood Vaccines Sales Quantity by Type (2024-2034) & (K Doses)
Table 108. Middle East, Africa and Latin America Childhood Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Childhood Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Childhood Vaccines Sales Quantity by Application (2018-2024) & (K Doses)
Table 111. Middle East, Africa and Latin America Childhood Vaccines Sales Quantity by Application (2024-2034) & (K Doses)
Table 112. Middle East, Africa and Latin America Childhood Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 113. Middle East, Africa and Latin America Childhood Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Childhood Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Childhood Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 116. Middle East, Africa and Latin America Childhood Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Childhood Vaccines Sales Quantity by Country (2018-2024) & (K Doses)
Table 118. Middle East, Africa and Latin America Childhood Vaccines Sales Quantity by Country (2024-2034) & (K Doses)
Table 119. GSK Company Information
Table 120. GSK Description and Overview
Table 121. GSK Childhood Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 122. GSK Childhood Vaccines Product and Services
Table 123. GSK Childhood Vaccines SWOT Analysis
Table 124. GSK Recent Developments
Table 125. Sanofi Company Information
Table 126. Sanofi Description and Overview
Table 127. Sanofi Childhood Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 128. Sanofi Childhood Vaccines Product and Services
Table 129. Sanofi Childhood Vaccines SWOT Analysis
Table 130. Sanofi Recent Developments
Table 131. Merck Company Information
Table 132. Merck Description and Overview
Table 133. Merck Childhood Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 134. Merck Childhood Vaccines Product and Services
Table 135. Merck Childhood Vaccines SWOT Analysis
Table 136. Merck Recent Developments
Table 137. Pfizer Company Information
Table 138. Pfizer Description and Overview
Table 139. Pfizer Childhood Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 140. Pfizer Childhood Vaccines Product and Services
Table 141. Pfizer Childhood Vaccines SWOT Analysis
Table 142. Pfizer Recent Developments
Table 143. Jintan Company Information
Table 144. Jintan Description and Overview
Table 145. Jintan Childhood Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 146. Jintan Childhood Vaccines Product and Services
Table 147. Jintan Childhood Vaccines SWOT Analysis
Table 148. Jintan Recent Developments
Table 149. CSL Company Information
Table 150. CSL Description and Overview
Table 151. CSL Childhood Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 152. CSL Childhood Vaccines Product and Services
Table 153. CSL Childhood Vaccines SWOT Analysis
Table 154. CSL Recent Developments
Table 155. MedImmune LLC Company Information
Table 156. MedImmune LLC Description and Overview
Table 157. MedImmune LLC Childhood Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 158. MedImmune LLC Childhood Vaccines Product and Services
Table 159. MedImmune LLC Childhood Vaccines SWOT Analysis
Table 160. MedImmune LLC Recent Developments
Table 161. J&J(Crucell) Company Information
Table 162. J&J(Crucell) Description and Overview
Table 163. J&J(Crucell) Childhood Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 164. J&J(Crucell) Childhood Vaccines Product and Services
Table 165. J&J(Crucell) Childhood Vaccines SWOT Analysis
Table 166. J&J(Crucell) Recent Developments
Table 167. China National Biotec Company Information
Table 168. China National Biotec Description and Overview
Table 169. China National Biotec Childhood Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 170. China National Biotec Childhood Vaccines Product and Services
Table 171. China National Biotec Childhood Vaccines SWOT Analysis
Table 172. China National Biotec Recent Developments
Table 173. Tiantan Company Information
Table 174. Tiantan Description and Overview
Table 175. Tiantan Childhood Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 176. Tiantan Childhood Vaccines Product and Services
Table 177. Tiantan Childhood Vaccines SWOT Analysis
Table 178. Tiantan Recent Developments
Table 179. Hualan Company Information
Table 180. Hualan Description and Overview
Table 181. Hualan Childhood Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 182. Hualan Childhood Vaccines Product and Services
Table 183. Hualan Recent Developments
Table 184. Kangtai Company Information
Table 185. Kangtai Description and Overview
Table 186. Kangtai Childhood Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 187. Kangtai Childhood Vaccines Product and Services
Table 188. Kangtai Recent Developments
Table 189. Hissen Company Information
Table 190. Hissen Description and Overview
Table 191. Hissen Childhood Vaccines Sales Quantity (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/Dose) and Gross Margin (2018-2024)
Table 192. Hissen Childhood Vaccines Product and Services
Table 193. Hissen Recent Developments
Table 194. Key Raw Materials Lists
Table 195. Raw Materials Key Suppliers Lists
Table 196. Childhood Vaccines Distributors List
Table 197. Childhood Vaccines Customers List
Table 198. Childhood Vaccines Market Trends
Table 199. Childhood Vaccines Market Drivers
Table 200. Childhood Vaccines Market Challenges
Table 201. Childhood Vaccines Market Restraints
Table 202. Research Programs/Design for This Report
Table 203. Key Data Information from Secondary Sources
Table 204. Key Data Information from Primary Sources
List of Figures
Figure 1. Childhood Vaccines Product Picture
Figure 2. Global Childhood Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Childhood Vaccines Market Share by Type in 2022 & 2034
Figure 4. Recombinant Vaccines Product Picture
Figure 5. Viral Vaccines Product Picture
Figure 6. Polysaccharide Vaccines Product Picture
Figure 7. Others Product Picture
Figure 8. Global Childhood Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global Childhood Vaccines Market Share by Application in 2022 & 2034
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Childhood Vaccines Report Years Considered
Figure 13. Global Childhood Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Childhood Vaccines Revenue 2018-2034 (US$ Million)
Figure 15. Global Childhood Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 16. Global Childhood Vaccines Sales Quantity 2018-2034 (K Doses)
Figure 17. Global Childhood Vaccines Sales Quantity Market Share by Region (2018-2024)
Figure 18. Global Childhood Vaccines Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Childhood Vaccines Sales Quantity YoY (2018-2034) & (K Doses)
Figure 20. North America Childhood Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Childhood Vaccines Sales Quantity YoY (2018-2034) & (K Doses)
Figure 22. Europe Childhood Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Childhood Vaccines Sales Quantity YoY (2018-2034) & (K Doses)
Figure 24. China Childhood Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Childhood Vaccines Sales Quantity YoY (2018-2034) & (K Doses)
Figure 26. APAC Childhood Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Childhood Vaccines Sales Quantity YoY (2018-2034) & (K Doses)
Figure 28. Middle East, Africa and Latin America Childhood Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Childhood Vaccines Sales Quantity in 2022
Figure 30. The Top 10 and Top 5 Players Market Share by Childhood Vaccines Revenue in 2022
Figure 31. Childhood Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Childhood Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Childhood Vaccines Revenue Market Share by Type (2018-2034)
Figure 34. Global Childhood Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Childhood Vaccines Revenue Market Share by Application (2018-2034)
Figure 36. North America Childhood Vaccines Revenue Market Share by Company in 2022
Figure 37. North America Childhood Vaccines Sales Quantity Market Share by Company in 2022
Figure 38. North America Childhood Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Childhood Vaccines Revenue Market Share by Type (2018-2034)
Figure 40. North America Childhood Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Childhood Vaccines Revenue Market Share by Application (2018-2034)
Figure 42. North America Childhood Vaccines Revenue Share by Country (2018-2034)
Figure 43. North America Childhood Vaccines Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. Childhood Vaccines Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Childhood Vaccines Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Childhood Vaccines Sales Quantity Market Share by Company in 2022
Figure 47. Europe Childhood Vaccines Revenue Market Share by Company in 2022
Figure 48. Europe Childhood Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Childhood Vaccines Revenue Market Share by Type (2018-2034)
Figure 50. Europe Childhood Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Childhood Vaccines Revenue Market Share by Application (2018-2034)
Figure 52. Europe Childhood Vaccines Revenue Share by Country (2018-2034)
Figure 53. Europe Childhood Vaccines Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Childhood Vaccines Revenue (2018-2034) & (US$ Million)
Figure 55. France Childhood Vaccines Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Childhood Vaccines Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Childhood Vaccines Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Childhood Vaccines Revenue (2018-2034) & (US$ Million)
Figure 59. China Childhood Vaccines Sales Quantity Market Share by Company in 2022
Figure 60. China Childhood Vaccines Revenue Market Share by Company in 2022
Figure 61. China Childhood Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Childhood Vaccines Revenue Market Share by Type (2018-2034)
Figure 63. China Childhood Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Childhood Vaccines Revenue Market Share by Application (2018-2034)
Figure 65. APAC Childhood Vaccines Sales Quantity Market Share by Company in 2022
Figure 66. APAC Childhood Vaccines Revenue Market Share by Company in 2022
Figure 67. APAC Childhood Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Childhood Vaccines Revenue Market Share by Type (2018-2034)
Figure 69. APAC Childhood Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Childhood Vaccines Revenue Market Share by Application (2018-2034)
Figure 71. APAC Childhood Vaccines Revenue Share by Region (2018-2034)
Figure 72. APAC Childhood Vaccines Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Childhood Vaccines Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Childhood Vaccines Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Childhood Vaccines Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Childhood Vaccines Revenue (2018-2034) & (US$ Million)
Figure 77. India Childhood Vaccines Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Childhood Vaccines Sales Quantity Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Childhood Vaccines Revenue Market Share by Company in 2022
Figure 80. Middle East, Africa and Latin America Childhood Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Childhood Vaccines Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Childhood Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Childhood Vaccines Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Childhood Vaccines Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Childhood Vaccines Revenue Share by Country (2018-2034)
Figure 86. Brazil Childhood Vaccines Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Childhood Vaccines Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Childhood Vaccines Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Childhood Vaccines Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Childhood Vaccines Revenue (2018-2034) & (US$ Million)
Figure 91. Childhood Vaccines Value Chain
Figure 92. Childhood Vaccines Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed